July 18, 2022

Bernadett S et al. European Urology, 2022

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Download Publication

You might also be interested by

Brochures

Immunohistochemistry (IHC) Biomarker List

November 10, 2021

Histopathology

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info

Brochures

Oncology & Immuno-Oncology Expertise

November 5, 2021

Histopathology

More info